Zurn Water Solutions Corporation

RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RXN stands at 11.44B. In comparison, AWK has a market cap of 28.65B. Regarding current trading prices, RXN is priced at $64.95, while AWK trades at $146.91.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RXN currently has a P/E ratio of N/A, whereas AWK's P/E ratio is 26.76. In terms of profitability, RXN's ROE is +0.14%, compared to AWK's ROE of +0.10%. Regarding short-term risk, RXN is more volatile compared to AWK. This indicates potentially higher risk in terms of short-term price fluctuations for RXN.

RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RXN stands at 11.44B. In comparison, SBS has a market cap of 14.07B. Regarding current trading prices, RXN is priced at $64.95, while SBS trades at $20.59.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RXN currently has a P/E ratio of N/A, whereas SBS's P/E ratio is 8.37. In terms of profitability, RXN's ROE is +0.14%, compared to SBS's ROE of +0.30%. Regarding short-term risk, RXN is more volatile compared to SBS. This indicates potentially higher risk in terms of short-term price fluctuations for RXN.

RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RXN stands at 11.44B. In comparison, WTRG has a market cap of 11.23B. Regarding current trading prices, RXN is priced at $64.95, while WTRG trades at $40.76.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RXN currently has a P/E ratio of N/A, whereas WTRG's P/E ratio is 18.78. In terms of profitability, RXN's ROE is +0.14%, compared to WTRG's ROE of +0.10%. Regarding short-term risk, RXN is more volatile compared to WTRG. This indicates potentially higher risk in terms of short-term price fluctuations for RXN.

RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RXN stands at 11.44B. In comparison, STRNY has a market cap of 10.78B. Regarding current trading prices, RXN is priced at $64.95, while STRNY trades at $35.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RXN currently has a P/E ratio of N/A, whereas STRNY's P/E ratio is 34.85. In terms of profitability, RXN's ROE is +0.14%, compared to STRNY's ROE of +0.10%. Regarding short-term risk, RXN is more volatile compared to STRNY. This indicates potentially higher risk in terms of short-term price fluctuations for RXN.

RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RXN stands at 11.44B. In comparison, UUGWF has a market cap of 10.13B. Regarding current trading prices, RXN is priced at $64.95, while UUGWF trades at $14.86.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RXN currently has a P/E ratio of N/A, whereas UUGWF's P/E ratio is 67.55. In terms of profitability, RXN's ROE is +0.14%, compared to UUGWF's ROE of +0.06%. Regarding short-term risk, RXN is less volatile compared to UUGWF. This indicates potentially lower risk in terms of short-term price fluctuations for RXN.

RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RXN stands at 11.44B. In comparison, UUGRY has a market cap of 10.02B. Regarding current trading prices, RXN is priced at $64.95, while UUGRY trades at $29.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RXN currently has a P/E ratio of N/A, whereas UUGRY's P/E ratio is 66.77. In terms of profitability, RXN's ROE is +0.14%, compared to UUGRY's ROE of +0.06%. Regarding short-term risk, RXN is more volatile compared to UUGRY. This indicates potentially higher risk in terms of short-term price fluctuations for RXN.

RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RXN stands at 11.44B. In comparison, SVTRF has a market cap of 9.72B. Regarding current trading prices, RXN is priced at $64.95, while SVTRF trades at $32.39.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RXN currently has a P/E ratio of N/A, whereas SVTRF's P/E ratio is 31.45. In terms of profitability, RXN's ROE is +0.14%, compared to SVTRF's ROE of +0.10%. Regarding short-term risk, RXN is more volatile compared to SVTRF. This indicates potentially higher risk in terms of short-term price fluctuations for RXN.

RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RXN stands at 11.44B. In comparison, GGDVY has a market cap of 5.29B. Regarding current trading prices, RXN is priced at $64.95, while GGDVY trades at $40.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RXN currently has a P/E ratio of N/A, whereas GGDVY's P/E ratio is 9.99. In terms of profitability, RXN's ROE is +0.14%, compared to GGDVY's ROE of +0.04%. Regarding short-term risk, RXN is more volatile compared to GGDVY. This indicates potentially higher risk in terms of short-term price fluctuations for RXN.

RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RXN stands at 11.44B. In comparison, GGDVF has a market cap of 5.03B. Regarding current trading prices, RXN is priced at $64.95, while GGDVF trades at $0.77.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RXN currently has a P/E ratio of N/A, whereas GGDVF's P/E ratio is 9.63. In terms of profitability, RXN's ROE is +0.14%, compared to GGDVF's ROE of +0.01%. Regarding short-term risk, RXN is more volatile compared to GGDVF. This indicates potentially higher risk in terms of short-term price fluctuations for RXN.

RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RXN stands at 11.44B. In comparison, BJWTY has a market cap of 3.15B. Regarding current trading prices, RXN is priced at $64.95, while BJWTY trades at $22.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RXN currently has a P/E ratio of N/A, whereas BJWTY's P/E ratio is 14.97. In terms of profitability, RXN's ROE is +0.14%, compared to BJWTY's ROE of +0.05%. Regarding short-term risk, RXN is more volatile compared to BJWTY. This indicates potentially higher risk in terms of short-term price fluctuations for RXN.

RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RXN stands at 11.44B. In comparison, AWR has a market cap of 3.09B. Regarding current trading prices, RXN is priced at $64.95, while AWR trades at $80.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RXN currently has a P/E ratio of N/A, whereas AWR's P/E ratio is 25.30. In terms of profitability, RXN's ROE is +0.14%, compared to AWR's ROE of +0.14%. Regarding short-term risk, RXN is more volatile compared to AWR. This indicates potentially higher risk in terms of short-term price fluctuations for RXN.

RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RXN stands at 11.44B. In comparison, BJWTF has a market cap of 3.01B. Regarding current trading prices, RXN is priced at $64.95, while BJWTF trades at $0.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RXN currently has a P/E ratio of N/A, whereas BJWTF's P/E ratio is 15.00. In terms of profitability, RXN's ROE is +0.14%, compared to BJWTF's ROE of +0.05%. Regarding short-term risk, RXN is more volatile compared to BJWTF. This indicates potentially higher risk in terms of short-term price fluctuations for RXN.

RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RXN stands at 11.44B. In comparison, PEGRF has a market cap of 2.95B. Regarding current trading prices, RXN is priced at $64.95, while PEGRF trades at $6.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RXN currently has a P/E ratio of N/A, whereas PEGRF's P/E ratio is -41.73. In terms of profitability, RXN's ROE is +0.14%, compared to PEGRF's ROE of -0.04%. Regarding short-term risk, RXN is more volatile compared to PEGRF. This indicates potentially higher risk in terms of short-term price fluctuations for RXN.

RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RXN stands at 11.44B. In comparison, CWT has a market cap of 2.90B. Regarding current trading prices, RXN is priced at $64.95, while CWT trades at $48.66.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RXN currently has a P/E ratio of N/A, whereas CWT's P/E ratio is 21.53. In terms of profitability, RXN's ROE is +0.14%, compared to CWT's ROE of +0.08%. Regarding short-term risk, RXN is more volatile compared to CWT. This indicates potentially higher risk in terms of short-term price fluctuations for RXN.

RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RXN stands at 11.44B. In comparison, SJW has a market cap of 1.86B. Regarding current trading prices, RXN is priced at $64.95, while SJW trades at $54.37.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RXN currently has a P/E ratio of N/A, whereas SJW's P/E ratio is 18.94. In terms of profitability, RXN's ROE is +0.14%, compared to SJW's ROE of +0.07%. Regarding short-term risk, RXN is less volatile compared to SJW. This indicates potentially lower risk in terms of short-term price fluctuations for RXN.

RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RXN stands at 11.44B. In comparison, MWTCY has a market cap of 1.60B. Regarding current trading prices, RXN is priced at $64.95, while MWTCY trades at $14.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RXN currently has a P/E ratio of N/A, whereas MWTCY's P/E ratio is 11.06. In terms of profitability, RXN's ROE is +0.14%, compared to MWTCY's ROE of +0.14%. Regarding short-term risk, RXN is less volatile compared to MWTCY. This indicates potentially lower risk in terms of short-term price fluctuations for RXN.

RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RXN stands at 11.44B. In comparison, PEGRY has a market cap of 1.56B. Regarding current trading prices, RXN is priced at $64.95, while PEGRY trades at $13.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RXN currently has a P/E ratio of N/A, whereas PEGRY's P/E ratio is -42.65. In terms of profitability, RXN's ROE is +0.14%, compared to PEGRY's ROE of -0.01%. Regarding short-term risk, RXN is less volatile compared to PEGRY. This indicates potentially lower risk in terms of short-term price fluctuations for RXN.

RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RXN stands at 11.44B. In comparison, CWAFF has a market cap of 1.42B. Regarding current trading prices, RXN is priced at $64.95, while CWAFF trades at $0.87.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RXN currently has a P/E ratio of N/A, whereas CWAFF's P/E ratio is 7.25. In terms of profitability, RXN's ROE is +0.14%, compared to CWAFF's ROE of +0.12%. Regarding short-term risk, RXN is less volatile compared to CWAFF. This indicates potentially lower risk in terms of short-term price fluctuations for RXN.

RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RXN stands at 11.44B. In comparison, MWTCF has a market cap of 1.35B. Regarding current trading prices, RXN is priced at $64.95, while MWTCF trades at $0.52.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RXN currently has a P/E ratio of N/A, whereas MWTCF's P/E ratio is 8.67. In terms of profitability, RXN's ROE is +0.14%, compared to MWTCF's ROE of +0.14%. Regarding short-term risk, RXN is more volatile compared to MWTCF. This indicates potentially higher risk in terms of short-term price fluctuations for RXN.

RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RXN stands at 11.44B. In comparison, ARIS has a market cap of 1.27B. Regarding current trading prices, RXN is priced at $64.95, while ARIS trades at $21.56.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RXN currently has a P/E ratio of N/A, whereas ARIS's P/E ratio is 26.62. In terms of profitability, RXN's ROE is +0.14%, compared to ARIS's ROE of +0.08%. Regarding short-term risk, RXN is less volatile compared to ARIS. This indicates potentially lower risk in terms of short-term price fluctuations for RXN.

RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RXN stands at 11.44B. In comparison, TTAPF has a market cap of 1.16B. Regarding current trading prices, RXN is priced at $64.95, while TTAPF trades at $0.29.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RXN currently has a P/E ratio of N/A, whereas TTAPF's P/E ratio is 14.50. In terms of profitability, RXN's ROE is +0.14%, compared to TTAPF's ROE of +0.18%. Regarding short-term risk, RXN is less volatile compared to TTAPF. This indicates potentially lower risk in terms of short-term price fluctuations for RXN.

RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RXN stands at 11.44B. In comparison, MSEXP has a market cap of 1.09B. Regarding current trading prices, RXN is priced at $64.95, while MSEXP trades at $629.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RXN currently has a P/E ratio of N/A, whereas MSEXP's P/E ratio is N/A. In terms of profitability, RXN's ROE is +0.14%, compared to MSEXP's ROE of +0.10%. Regarding short-term risk, RXN is more volatile compared to MSEXP. This indicates potentially higher risk in terms of short-term price fluctuations for RXN.

RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RXN stands at 11.44B. In comparison, TTAPY has a market cap of 1.08B. Regarding current trading prices, RXN is priced at $64.95, while TTAPY trades at $13.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RXN currently has a P/E ratio of N/A, whereas TTAPY's P/E ratio is 12.74. In terms of profitability, RXN's ROE is +0.14%, compared to TTAPY's ROE of +0.18%. Regarding short-term risk, RXN is more volatile compared to TTAPY. This indicates potentially higher risk in terms of short-term price fluctuations for RXN.

RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RXN stands at 11.44B. In comparison, MSEX has a market cap of 1.08B. Regarding current trading prices, RXN is priced at $64.95, while MSEX trades at $60.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RXN currently has a P/E ratio of N/A, whereas MSEX's P/E ratio is 24.93. In terms of profitability, RXN's ROE is +0.14%, compared to MSEX's ROE of +0.10%. Regarding short-term risk, RXN is more volatile compared to MSEX. This indicates potentially higher risk in terms of short-term price fluctuations for RXN.

RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RXN stands at 11.44B. In comparison, TTWPF has a market cap of 917.70M. Regarding current trading prices, RXN is priced at $64.95, while TTWPF trades at $0.23.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RXN currently has a P/E ratio of N/A, whereas TTWPF's P/E ratio is 11.50. In terms of profitability, RXN's ROE is +0.14%, compared to TTWPF's ROE of +0.18%. Regarding short-term risk, RXN is more volatile compared to TTWPF. This indicates potentially higher risk in terms of short-term price fluctuations for RXN.

RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RXN stands at 11.44B. In comparison, AHWSF has a market cap of 862.65M. Regarding current trading prices, RXN is priced at $64.95, while AHWSF trades at $8.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RXN currently has a P/E ratio of N/A, whereas AHWSF's P/E ratio is 15.58. In terms of profitability, RXN's ROE is +0.14%, compared to AHWSF's ROE of +0.02%. Regarding short-term risk, RXN is less volatile compared to AHWSF. This indicates potentially lower risk in terms of short-term price fluctuations for RXN.

RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RXN stands at 11.44B. In comparison, SGXXF has a market cap of 578.98M. Regarding current trading prices, RXN is priced at $64.95, while SGXXF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RXN currently has a P/E ratio of N/A, whereas SGXXF's P/E ratio is -0.00. In terms of profitability, RXN's ROE is +0.14%, compared to SGXXF's ROE of -0.57%. Regarding short-term risk, RXN is less volatile compared to SGXXF. This indicates potentially lower risk in terms of short-term price fluctuations for RXN.

RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RXN stands at 11.44B. In comparison, BOTRF has a market cap of 486.35M. Regarding current trading prices, RXN is priced at $64.95, while BOTRF trades at $0.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RXN currently has a P/E ratio of N/A, whereas BOTRF's P/E ratio is 3.40. In terms of profitability, RXN's ROE is +0.14%, compared to BOTRF's ROE of +0.07%. Regarding short-term risk, RXN is more volatile compared to BOTRF. This indicates potentially higher risk in terms of short-term price fluctuations for RXN.

RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RXN stands at 11.44B. In comparison, YORW has a market cap of 472.19M. Regarding current trading prices, RXN is priced at $64.95, while YORW trades at $32.79.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RXN currently has a P/E ratio of N/A, whereas YORW's P/E ratio is 23.93. In terms of profitability, RXN's ROE is +0.14%, compared to YORW's ROE of +0.09%. Regarding short-term risk, RXN is more volatile compared to YORW. This indicates potentially higher risk in terms of short-term price fluctuations for RXN.

RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RXN stands at 11.44B. In comparison, CWCO has a market cap of 373.09M. Regarding current trading prices, RXN is priced at $64.95, while CWCO trades at $23.44.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RXN currently has a P/E ratio of N/A, whereas CWCO's P/E ratio is 20.93. In terms of profitability, RXN's ROE is +0.14%, compared to CWCO's ROE of +0.00%. Regarding short-term risk, RXN is more volatile compared to CWCO. This indicates potentially higher risk in terms of short-term price fluctuations for RXN.

RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RXN stands at 11.44B. In comparison, ARTNA has a market cap of 355.20M. Regarding current trading prices, RXN is priced at $64.95, while ARTNA trades at $34.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RXN currently has a P/E ratio of N/A, whereas ARTNA's P/E ratio is 17.42. In terms of profitability, RXN's ROE is +0.14%, compared to ARTNA's ROE of +0.09%. Regarding short-term risk, RXN is less volatile compared to ARTNA. This indicates potentially lower risk in terms of short-term price fluctuations for RXN.

RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RXN stands at 11.44B. In comparison, ARTNB has a market cap of 345.20M. Regarding current trading prices, RXN is priced at $64.95, while ARTNB trades at $33.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RXN currently has a P/E ratio of N/A, whereas ARTNB's P/E ratio is 16.79. In terms of profitability, RXN's ROE is +0.14%, compared to ARTNB's ROE of +0.09%. Regarding short-term risk, RXN is more volatile compared to ARTNB. This indicates potentially higher risk in terms of short-term price fluctuations for RXN.

RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RXN stands at 11.44B. In comparison, VWTR has a market cap of 288.22M. Regarding current trading prices, RXN is priced at $64.95, while VWTR trades at $15.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RXN currently has a P/E ratio of N/A, whereas VWTR's P/E ratio is 9.29. In terms of profitability, RXN's ROE is +0.14%, compared to VWTR's ROE of +0.17%. Regarding short-term risk, RXN is more volatile compared to VWTR. This indicates potentially higher risk in terms of short-term price fluctuations for RXN.

RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RXN stands at 11.44B. In comparison, GWRS has a market cap of 285.71M. Regarding current trading prices, RXN is priced at $64.95, while GWRS trades at $10.41.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RXN currently has a P/E ratio of N/A, whereas GWRS's P/E ratio is 43.38. In terms of profitability, RXN's ROE is +0.14%, compared to GWRS's ROE of +0.12%. Regarding short-term risk, RXN is more volatile compared to GWRS. This indicates potentially higher risk in terms of short-term price fluctuations for RXN.

RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RXN stands at 11.44B. In comparison, HEOFF has a market cap of 280.83M. Regarding current trading prices, RXN is priced at $64.95, while HEOFF trades at $3.12.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RXN currently has a P/E ratio of N/A, whereas HEOFF's P/E ratio is -312.01. In terms of profitability, RXN's ROE is +0.14%, compared to HEOFF's ROE of -0.03%. Regarding short-term risk, RXN is more volatile compared to HEOFF. This indicates potentially higher risk in terms of short-term price fluctuations for RXN.

RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RXN stands at 11.44B. In comparison, PCYO has a market cap of 249.43M. Regarding current trading prices, RXN is priced at $64.95, while PCYO trades at $10.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RXN currently has a P/E ratio of N/A, whereas PCYO's P/E ratio is 17.56. In terms of profitability, RXN's ROE is +0.14%, compared to PCYO's ROE of +0.11%. Regarding short-term risk, RXN is more volatile compared to PCYO. This indicates potentially higher risk in terms of short-term price fluctuations for RXN.

RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RXN stands at 11.44B. In comparison, CDZI has a market cap of 248.05M. Regarding current trading prices, RXN is priced at $64.95, while CDZI trades at $3.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RXN currently has a P/E ratio of N/A, whereas CDZI's P/E ratio is -5.72. In terms of profitability, RXN's ROE is +0.14%, compared to CDZI's ROE of -1.05%. Regarding short-term risk, RXN is less volatile compared to CDZI. This indicates potentially lower risk in terms of short-term price fluctuations for RXN.

RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RXN stands at 11.44B. In comparison, CDZIP has a market cap of 244.54M. Regarding current trading prices, RXN is priced at $64.95, while CDZIP trades at $18.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RXN currently has a P/E ratio of N/A, whereas CDZIP's P/E ratio is -21.89. In terms of profitability, RXN's ROE is +0.14%, compared to CDZIP's ROE of -1.05%. Regarding short-term risk, RXN is more volatile compared to CDZIP. This indicates potentially higher risk in terms of short-term price fluctuations for RXN.

RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RXN stands at 11.44B. In comparison, AWAEF has a market cap of 206.05M. Regarding current trading prices, RXN is priced at $64.95, while AWAEF trades at $0.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RXN currently has a P/E ratio of N/A, whereas AWAEF's P/E ratio is 2.67. In terms of profitability, RXN's ROE is +0.14%, compared to AWAEF's ROE of +0.06%. Regarding short-term risk, RXN is less volatile compared to AWAEF. This indicates potentially lower risk in terms of short-term price fluctuations for RXN.

RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RXN stands at 11.44B. In comparison, CETI has a market cap of 79.42M. Regarding current trading prices, RXN is priced at $64.95, while CETI trades at $0.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RXN currently has a P/E ratio of N/A, whereas CETI's P/E ratio is -14.00. In terms of profitability, RXN's ROE is +0.14%, compared to CETI's ROE of -4.82%. Regarding short-term risk, RXN is less volatile compared to CETI. This indicates potentially lower risk in terms of short-term price fluctuations for RXN.

RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RXN stands at 11.44B. In comparison, MPIR has a market cap of 43.20M. Regarding current trading prices, RXN is priced at $64.95, while MPIR trades at $0.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RXN currently has a P/E ratio of N/A, whereas MPIR's P/E ratio is -0.92. In terms of profitability, RXN's ROE is +0.14%, compared to MPIR's ROE of +0.51%. Regarding short-term risk, RXN is less volatile compared to MPIR. This indicates potentially lower risk in terms of short-term price fluctuations for RXN.

RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RXN stands at 11.44B. In comparison, DOMWF has a market cap of 17.11M. Regarding current trading prices, RXN is priced at $64.95, while DOMWF trades at $0.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RXN currently has a P/E ratio of N/A, whereas DOMWF's P/E ratio is -5.00. In terms of profitability, RXN's ROE is +0.14%, compared to DOMWF's ROE of -0.28%. Regarding short-term risk, RXN is less volatile compared to DOMWF. This indicates potentially lower risk in terms of short-term price fluctuations for RXN.

RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RXN stands at 11.44B. In comparison, CNQQF has a market cap of 10.11M. Regarding current trading prices, RXN is priced at $64.95, while CNQQF trades at $0.14.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RXN currently has a P/E ratio of N/A, whereas CNQQF's P/E ratio is -2.80. In terms of profitability, RXN's ROE is +0.14%, compared to CNQQF's ROE of -0.48%. Regarding short-term risk, RXN is less volatile compared to CNQQF. This indicates potentially lower risk in terms of short-term price fluctuations for RXN.

RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RXN stands at 11.44B. In comparison, PUFLF has a market cap of 4.65M. Regarding current trading prices, RXN is priced at $64.95, while PUFLF trades at $0.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RXN currently has a P/E ratio of N/A, whereas PUFLF's P/E ratio is -13.13. In terms of profitability, RXN's ROE is +0.14%, compared to PUFLF's ROE of +0.15%. Regarding short-term risk, RXN is more volatile compared to PUFLF. This indicates potentially higher risk in terms of short-term price fluctuations for RXN.

RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RXN stands at 11.44B. In comparison, AEPT has a market cap of 307296.00. Regarding current trading prices, RXN is priced at $64.95, while AEPT trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RXN currently has a P/E ratio of N/A, whereas AEPT's P/E ratio is -0.07. In terms of profitability, RXN's ROE is +0.14%, compared to AEPT's ROE of +3.07%. Regarding short-term risk, RXN is more volatile compared to AEPT. This indicates potentially higher risk in terms of short-term price fluctuations for RXN.

RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RXN stands at 11.44B. In comparison, HYFXF has a market cap of 78529.00. Regarding current trading prices, RXN is priced at $64.95, while HYFXF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RXN currently has a P/E ratio of N/A, whereas HYFXF's P/E ratio is N/A. In terms of profitability, RXN's ROE is +0.14%, compared to HYFXF's ROE of -0.11%. Regarding short-term risk, RXN is less volatile compared to HYFXF. This indicates potentially lower risk in terms of short-term price fluctuations for RXN.

RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RXN stands at 11.44B. In comparison, ACGPF comparison data is unavailable. Regarding current trading prices, RXN is priced at $64.95, while ACGPF trades at $55.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RXN currently has a P/E ratio of N/A, whereas ACGPF's P/E ratio is N/A. In terms of profitability, RXN's ROE is +0.14%, compared to ACGPF's ROE of +0.05%. Regarding short-term risk, RXN is more volatile compared to ACGPF. This indicates potentially higher risk in terms of short-term price fluctuations for RXN.

RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RXN stands at 11.44B. In comparison, TORW comparison data is unavailable. Regarding current trading prices, RXN is priced at $64.95, while TORW trades at $90.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RXN currently has a P/E ratio of N/A, whereas TORW's P/E ratio is 43.27. In terms of profitability, RXN's ROE is +0.14%, compared to TORW's ROE of N/A. Regarding short-term risk, RXN is more volatile compared to TORW. This indicates potentially higher risk in terms of short-term price fluctuations for RXN.